Cash Flow from Financial Activities: The net amount of cash transactions used in funding activities.
Crinetics Pharmaceuticals, Inc. (CRNX) had Cash Flow from Financial Activities of $14.58M for the most recently reported fiscal quarter, ending 2025-09-30.
| Income Statement Financials | |
$0.14M |
|
$-130.09M |
|
-- |
|
$0.14M |
|
$142.73M |
|
$-142.59M |
|
$12.49M |
|
$-130.09M |
|
$-130.09M |
|
$-130.09M |
|
$-130.09M |
|
$-130.09M |
|
$-130.09M |
|
$-142.59M |
|
$-145.18M |
|
94.22M |
|
94.22M |
|
$-1.38 |
|
$-1.38 |
|
| Balance Sheet Financials | |
$1.12B |
|
$14.38M |
|
$74.76M |
|
$1.20B |
|
$74.16M |
|
-- |
|
$49.71M |
|
$123.86M |
|
$1.07B |
|
$1.07B |
|
$1.07B |
|
94.55M |
|
| Cash Flow Statement Financials | |
$-285.02M |
|
$116.80M |
|
|
Cash Flow from Financial Activities |
$14.58M |
$265.85M |
|
$112.20M |
|
$-153.64M |
|
$69.30M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
15.12 |
|
-- |
|
-- |
|
-- |
|
-- |
|
100.00% |
|
-99710.48% |
|
-99710.48% |
|
-- |
|
-90972.73% |
|
-90972.73% |
|
$-290.32M |
|
-- |
|
-- |
|
-- |
|
0.00 |
|
-- |
|
-- |
|
-- |
|
-12.13% |
|
-12.13% |
|
-10.88% |
|
-12.13% |
|
$11.34 |
|
$-3.08 |
|
$-3.03 |
|